Drug resistance of cancer cells probed

Humphrey visual field findings in hydroxychloroquine toxicity.

Eye (London, England)·2011

Comparison of MRSASelect Agar, CHROMagar Methicillin-Resistant Staphylococcus aureus (MRSA) Medium, and Xpert MRSA PCR for detection of MRSA in Nares: diagnostic accuracy for surveillance samples with various bacterial densities.

Journal of clinical microbiology·2009

Retinopathy of prematurity: evaluation of risk factors.

International ophthalmology·2000

Degeneration of cone photoreceptors induced by expression of the Mas1 protooncogene.

Experimental neurology·2000

Ocular injuries from paintball pellets.

Ophthalmology·1999

Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet.

Ophthalmology·1996

The Virtual Biotech: A multi-agent AI framework for therapeutic discovery and development.

Science (New York, N.Y.)·2026

Parsing heterogeneity in autism spectrum disorder.

Science (New York, N.Y.)·2026

Noise and diversity can boost stability.

Science (New York, N.Y.)·2026

In search of past genetics.

Science (New York, N.Y.)·2026

A viral origin for RNA-guided immunity.

Science (New York, N.Y.)·2026

Future forests.

Science (New York, N.Y.)·2026

Onvansertib-mediated PLK1 inhibition impairs spermatogenesis in the murine testis.

Asian journal of andrology·2026

RHOA Deletion Downregulates CD19 and Promotes Dysfunctional Immune Microenvironments in CAR-T Resistant Large B-cell Lymphomas.

Blood cancer discovery·2026

BUB1B Mitotic Kinase Dependency Reveals CENP-E Inhibition as a Tractable Approach for Castration and Enzalutamide Resistant Prostate Cancer.

Cancer research·2026

Emerging therapeutic strategies and clinical development of investigational agents for conventional chondrosarcoma.

Expert opinion on investigational drugs·2026

MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis.

Future oncology (London, England)·2026

Real-world treatment patterns in men with metastatic hormone-sensitive prostate cancer in Europe and Asia between 2020 and 2024.

The oncologist·2026

Related Experiment Videos

Drug resistance of cancer cells probed

Related Concept Videos

Humphrey visual field findings in hydroxychloroquine toxicity.

Comparison of MRSASelect Agar, CHROMagar Methicillin-Resistant Staphylococcus aureus (MRSA) Medium, and Xpert MRSA PCR for detection of MRSA in Nares: diagnostic accuracy for surveillance samples with various bacterial densities.

Retinopathy of prematurity: evaluation of risk factors.

Degeneration of cone photoreceptors induced by expression of the Mas1 protooncogene.

Ocular injuries from paintball pellets.

Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet.

The Virtual Biotech: A multi-agent AI framework for therapeutic discovery and development.

Parsing heterogeneity in autism spectrum disorder.

Noise and diversity can boost stability.

In search of past genetics.

A viral origin for RNA-guided immunity.

Future forests.

Onvansertib-mediated PLK1 inhibition impairs spermatogenesis in the murine testis.

RHOA Deletion Downregulates CD19 and Promotes Dysfunctional Immune Microenvironments in CAR-T Resistant Large B-cell Lymphomas.

BUB1B Mitotic Kinase Dependency Reveals CENP-E Inhibition as a Tractable Approach for Castration and Enzalutamide Resistant Prostate Cancer.

Emerging therapeutic strategies and clinical development of investigational agents for conventional chondrosarcoma.

MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis.

Real-world treatment patterns in men with metastatic hormone-sensitive prostate cancer in Europe and Asia between 2020 and 2024.

Related Experiment Videos

Drug resistance of cancer cells probed

Related Concept Videos

Related Articles